AC Immune SA (ACIU) Stock: Exploring a Year of Highs, Lows, and Trading Volume

ELVT Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. AC Immune SA’s current trading price is -5.25% away from its 52-week high, while its distance from the 52-week low is 156.32%. The stock’s price range during this period has varied between $1.90 and $5.14. The company, active in the Healthcare sector, saw a trading volume of around 0.98 million for the day, considerably higher average daily volume of 0.83 million observed over the last three months.

AC Immune SA’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $5.14 on 12/28/23, with the lowest value being $1.90 on 06/23/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

How Financial Performance Impacts Market Capitalization

AC Immune SA (ACIU) has experienced a quarterly rise of 25.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 483.10M and boasts a workforce of 161 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.22, with a change in price of +0.30. Similarly, AC Immune SA recorded 582,233 in trading volume during the last 100 days, posting a change of +6.56%.

How ACIU’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ACIU stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.

ACIU Stock Stochastic Average

As of today, the raw stochastic average of AC Immune SA over the last 50 days is at 97.04%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 96.99%. Further, the company’s Stochastic %K and %D values for the last 20 days were 90.60% and 91.51%, respectively.

ACIU Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -2.60% this year. Over the last six months, there has been a weaker performance of 39.14%. The price of ACIU fallen by 104.62% during the last 30 days period. For the last 5-days stocks have improved 22.67%.

Most Popular